Loading...
12 US Inhibitors Reports
Country Covered: US
Study Period: 2021 - 2030
Major Players: Merck, AstraZeneca, Eli Lilly and Company, Boehringer Ingelheim, Novartis
Country Covered: US
Study Period: 2019 - 2030
Major Players: Abbvie, Johnson & Johnson, Novartis, Eli Lilly and Company, GlaxoSmithKline
Country Covered: US
Study Period: 2019 - 2030
Major Players: Abbott Laboratories, AstraZeneca, Bayer, Boehringer Ingelheim, Amgen
Country Covered: US
Study Period: 2019 - 2030
Major Players: Boehringer Ingelheim, Roche, AstraZeneca, Novartis, Bayer
Country Covered: US
Study Period: 2019 - 2030
Major Players: Bayer, Pfizer, Takeda Pharmaceuticals, Zydus Group, AstraZeneca
Country Covered: US
Study Period: 2019 - 2030
Major Players: Sun Pharmaceuticals Industries, Bayer, Takeda Pharmaceuticals, Torrent Pharmaceuticals, Pfizer
Country Covered: US
Study Period: 2019 - 2030
Major Players: Bristol-Myers Squibb, Regeneron Pharmaceuticals, Roche, AstraZeneca, Merck
Country Covered: US
Study Period: 2021 - 2030
Major Players: Teva Pharmaceutical Industries, Amneal Pharmaceuticals, Viatris, Daiichi Sankyo, Sun Pharmaceuticals Industries
Country Covered: US
Study Period: 2019 - 2030
Major Players: Merck, AstraZeneca, Boehringer Ingelheim, Pfizer, Eli Lilly and Company
Country Covered: US
Study Period: 2019 - 2030
Major Players: Sun Pharmaceuticals Industries, Novartis, Teva Pharmaceutical Industries, Mylan, Dr. Reddy’s Laboratories
Country Covered: US
Study Period: 2019 - 2030
Major Players: CSL Behring, Takeda Pharmaceuticals, Pharming Technologies B.V., KalVista Pharmaceuticals, BioCryst Pharmaceuticals
Country Covered: US
Study Period: 2019 - 2030
Major Players: UCB, Pfizer, Johnson & Johnson, Amgen, Abbvie